At the end of June 2026, Miami-based intimate-wellness startup Mila announced it had closed an oversubscribed $2.5 million pre-seed round led by Mensch VC, with participation from Sticker Ventures and a roster of angels drawn from Spotify, Dyson, Tetra Pak, and BrewDog. The raise, first reported by Forbes and Beauty Independent on June 30, funds a female-founded brand pitching itself explicitly as the "beauty era" of intimate care.

Why It Matters

Mila lands amid a wave of small but telling sexual-wellness rounds — following brands framing intimacy as everyday self-care rather than a taboo purchase — and reinforces that the money is increasingly betting on aesthetics, ritual, and brand as the differentiator in a hardware category where the core technology (air-pulse, vibration) has commoditized. For device makers, a "4-in-1" product from a design-led newcomer is another sign that consumers reward experience and packaging over raw feature counts. For investors, a consumer-angel-heavy pre-seed shows sexual wellness continuing its migration from stigmatized niche toward the mainstream beauty-and-wellness capital stack.

Mila's thesis is a pointed one: while the broader beauty industry has turned nearly every body part into a ritual with premium, design-led products, the intimate-care category has seen little real innovation since suction (air-pulse) technology arrived more than 15 years ago. Co-founder Ada Trujillo said the company saw "an opportunity to build for a generation of consumers who have turned self-care into a lifestyle," and co-founder Kim Aviv argued that "women are ready for a more modern approach to intimate wellness." The early portfolio pairs hardware and consumable: Aura, a patent-pending 4-in-1 intimate wellness device, and Bloom, a hydrating intimate gliding mist.

The investor mix is itself a tell. Angels from consumer-hardware and consumer-brand powerhouses (Dyson for engineering, Spotify and BrewDog for brand-building) signal that Mila is being underwritten as a design-and-brand play, not a clinical device company — the same skincare-brand playbook that reshaped adjacent categories like menstrual care and menopause.

Sources

Update — 2026-07-12

Initial entry — story first created.